American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Salesforce
CRM
|
+$306M |
| 2 |
Church & Dwight Co
CHD
|
+$182M |
| 3 |
Lattice Semiconductor
LSCC
|
+$165M |
| 4 |
UnitedHealth
UNH
|
+$157M |
| 5 |
Meta Platforms (Facebook)
META
|
+$149M |
Top Sells
| 1 |
Humana
HUM
|
+$292M |
| 2 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$265M |
| 3 |
Air Products & Chemicals
APD
|
+$200M |
| 4 |
HES
Hess
HES
|
+$191M |
| 5 |
Idexx Laboratories
IDXX
|
+$182M |
Sector Composition
| 1 | Technology | 24.43% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.47% |
| 4 | Consumer Discretionary | 12.31% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Five Star Bancorp
FSBC
$701M
| $1.35M | ﹤0.01% |
51,637
-20
| -0% | -$524 |
|
1952
Elanco Animal Health
ELAN
$9.21B
| $1.35M | ﹤0.01% |
90,326
+25,978
| +40% | +$387K |
|
1953
Koppers
KOP
$567M
| $1.34M | ﹤0.01% |
26,208
+7,386
| +39% | +$378K |
|
1954
Lennar Class B
LEN.B
$34B
| $1.34M | ﹤0.01% |
10,503
+92
| +0.9% | +$11.7K |
|
1955
Primis Financial Corp
FRST
$269M
| $1.33M | ﹤0.01% |
104,987
+1,410
| +1% | +$17.9K |
|
1956
Flowers Foods
FLO
$2.9B
| $1.33M | ﹤0.01% |
58,893
-3,138
| -5% | -$70.6K |
|
1957
Xencor
XNCR
$613M
| $1.32M | ﹤0.01% |
62,290
+16,772
| +37% | +$356K |
|
1958
Hexcel
HXL
$4.93B
| $1.32M | ﹤0.01% |
17,892
+726
| +4% | +$53.5K |
|
1959
Thermon Group Holdings
THR
$844M
| $1.32M | ﹤0.01% |
40,475
+13,695
| +51% | +$446K |
|
1960
Mayville Engineering Co
MEC
$289M
| $1.32M | ﹤0.01% |
91,294
-6,762
| -7% | -$97.5K |
|
1961
Aris Water Solutions
ARIS
$787M
| $1.32M | ﹤0.01% |
156,875
+55,933
| +55% | +$469K |
|
1962
Civista Bancshares
CIVB
$402M
| $1.3M | ﹤0.01% |
70,721
+1,448
| +2% | +$26.7K |
|
1963
Corcept Therapeutics
CORT
$7.68B
| $1.29M | ﹤0.01% |
39,709
-28,539
| -42% | -$927K |
|
1964
Omnicell
OMCL
$1.46B
| $1.29M | ﹤0.01% |
34,241
+18,293
| +115% | +$688K |
|
1965
Lazard
LAZ
$5.25B
| $1.28M | ﹤0.01% |
36,882
-3,430
| -9% | -$119K |
|
1966
Globus Medical
GMED
$7.93B
| $1.28M | ﹤0.01% |
24,045
+94
| +0.4% | +$5.01K |
|
1967
Ramaco Resources Class B
METCB
$1.04B
| $1.28M | ﹤0.01% |
98,517
+32,405
| +49% | +$421K |
|
1968
Innoviva
INVA
$1.22B
| $1.28M | ﹤0.01% |
79,756
-688,303
| -90% | -$11M |
|
1969
Carnival PLC
CUK
$37.7B
| $1.26M | ﹤0.01% |
74,744
+30,690
| +70% | +$517K |
|
1970
Ecovyst
ECVT
$1.06B
| $1.26M | ﹤0.01% |
128,968
+29,492
| +30% | +$288K |
|
1971
Atlanticus Holdings
ATLC
$1.09B
| $1.26M | ﹤0.01% |
32,558
+450
| +1% | +$17.4K |
|
1972
Royalty Pharma
RPRX
$15.7B
| $1.26M | ﹤0.01% |
44,704
+2,106
| +5% | +$59.2K |
|
1973
Nasdaq
NDAQ
$53.9B
| $1.25M | ﹤0.01% |
21,577
-2,815
| -12% | -$164K |
|
1974
Glacier Bancorp
GBCI
$5.8B
| $1.25M | ﹤0.01% |
30,275
+6,375
| +27% | +$263K |
|
1975
Universal Electronics
UEIC
$62.3M
| $1.25M | ﹤0.01% |
132,934
-28
| -0% | -$263 |
|